Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Myelodysplastic syndrome (MDS), Myelofibrosis, Polycythaemia, Thrombocythaemia
Closed
Phase 1
This study is looking at a new drug called INCB057643 to treat cancers that affect how well the bone marrow works.
It is open to people who have:
features of myelodysplastic syndrome and myeloproliferative neoplasm when diagnosed. This is myelodysplastic/myeloproliferative overlap syndrome.
Recruitment start: 1 September 2020
Recruitment end: 2 October 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Emma Searle
Incyte Corporation
Last reviewed: 05 Jan 2026
CRUK internal database number: 18044
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
